Answers are grounded in this paper and cite their sources.
This review explores organ-on-a-chip technology, highlighting its applications for COVID-19 vaccine development and drug testing.
Coronavirus disease (COVID-19) pandemic was occurred and continuously getting worse on 2020. A first patient of COVID-19 was reported on Wuhan City, China on Dec 2019. There is no vaccines and target drugs for COVID-19 because it is a new evolved infectious disease. The corona virus of COVID-19 was rapid spread to many peoples and nations within several months. World Health Organization (WHO) announced that 216 countries or areas in the world was infected by COVID-19 with 16,523,815 confirmed cases and 655,112 confirmed deaths on 29 July 2020 [1]. Although vaccines and drugs for COVID-19 are highly needed, developing vaccines and new drugs require high cost and long time. Recently organ-on-a-chip or human-on-a-chip was suggested a new test method to reduce cost and time for developing a new drug [2,3]. Especially these organ-on-a-chip can replace an animal in a non-clinical test [2,3]. In this review, recent developed organ-on-a-chips and their various applications are explained
No takes yet. Share an insight, caveat, or question.
Young Ho Kim (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: